Coronavirus in Ecuador: an opinion from the Academia

Main Article Content

Santiago Guerrero


This is the third time that a zoonotic coronavirus has infected various human populations. This new virus, classified as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), is the causative agent of the new pandemic outbreak called COVID-19 (coronavirus disease 2019). The international research carried out around this new outbreak was so effective that shortly thereafter the genome of the virus, its biology and its main epidemiological aspects were determined. To date, 1962 positive cases of SARS-CoV-2 have been reported in Ecuador, situation that has caused great concern among Ecuadorian academics and society. Thus, in this opinion article, the main research carried out internationally on the SARS-CoV-2 will be detailed, the importance of the Academia in healthcare decision-making will be discussed and the role of fundamental research to hold a possible outbreak in Ecuador will be mentioned.
Abstract 456 | PDF (Español (España)) Downloads 129 PDF Downloads 96 HTML (Español (España)) Downloads 47 EPUB (Español (España)) Downloads 6 XML (Español (España)) Downloads 0


Balajee, S. A., Pasi, O. G., Etoundi, A. G. M., Rzeszotarski, P., Do, T. T., Hennessee, I., … Mounts, A. W. (2017, December 1). Sustainable model for public health emergency operations centers for global settings. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC).

Brito, J., Camacho, M. A., Romero, V., & Vallejo, A. F. (2019). Mamíferos del Ecuador. Versión 2019.0. Retrieved February 25, 2020, from

Cohen, J. (2020). Can an anti-HIV combination or other existing drugs outwit the new coronavirus? Science.

Corman, Victor M, Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., … Drosten, C. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 25(3).

Corman, Victor Max, Rasche, A., Diallo, T. D., Cottontail, V. M., Stöcker, A., Souza, B. F. de C. D., … Drexler, J. F. (2013). Highly diversified coronaviruses in neotropical bats. Journal of General Virology, 94(PART9), 1984–1994.

Cui, J., Li, F., & Shi, Z. L. (2019, March 1). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. Nature Publishing Group.

Eccles, R. (2005, November). Understanding the symptoms of the common cold and influenza. Lancet Infectious Diseases.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506.

Maxmen, A. (2020). More than 80 clinical trials launch to test coronavirus treatments. Nature 2020 578:7795.

MSP. (2020). Ministerio de Salud Pública del Ecuador. «Comunicados oficales del Ministerio de Salud Pública del Ecuador». En: ed. por

Perlman, S. (2020). Another Decade, Another Coronavirus. New England Journal of Medicine.

Pineda-Leguízamo, R., Miranda-Novales, G., & Villasis-Keever, M. Á. (2018). La importancia de los reportes de casos clínicos en la investigación. Revista Alergia México, 65(1), 92.

Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., … Lu, J. (2020). On the origin and continuing evolution of SARS-CoV-2. National Science Review.

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., … McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.).